GB Sciences, Inc.
OTC: GBLX0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Andrea Small-Howard
- Employees
- 2
- Headquarters
- Las Vegas, United States
- IPO year
- 2008
- Market cap
- $122.1K
- Website
- https://www.gbsciences.com
Loading GBLX…
Loading profile data…Frequently asked questions about GBLX
What does GB Sciences, Inc. (GBLX) do?
Operating across North America and Europe, GB Sciences, Inc. is dedicated to the research and development of plant-based pharmaceuticals. The company specializes in crafting cannabinoid-inspired medications and complex therapeutic formulations intended for the prescription drug market. Its extensive intellectual property portfolio addresses a va...
Where does GBLX trade?
GB Sciences, Inc. (GBLX) trades on the Other OTC.
What sector is GBLX in?
GB Sciences, Inc. (GBLX) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of GB Sciences, Inc.?
Andrea Small-Howard is the chief executive officer of GB Sciences, Inc. (GBLX).
Where is GB Sciences, Inc. headquartered?
GB Sciences, Inc. is headquartered in United States.
Does GBLX pay a dividend?
GB Sciences, Inc. (GBLX) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did GBLX go public?
GB Sciences, Inc. (GBLX) completed its initial public offering in 2008.